lactic acid has been researched along with shikonin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assimopoulou, AN; Kontogiannopoulos, KN; Panayiotou, C; Papageorgiou, VP; Tsivintzelis, I | 1 |
| Chen, J; Hu, X; Jiang, Z; Wang, B; Wang, Y; Xie, J | 1 |
| Chao, TK; Huang, RL; Huang, TS; Lai, HC; Liao, YP; Shen, HY; Su, PH; Wang, YC | 1 |
| Chen, G; He, Y; Hou, J; Huang, Y; Lin, F; Long, L; Peng, T; Wang, R; Xiong, W; Xu, Q | 1 |
4 other study(ies) available for lactic acid and shikonin
| Article | Year |
|---|---|
Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications.
Topics: Administration, Cutaneous; Bandages; Cellulose; Drug Combinations; Drugs, Chinese Herbal; Electrochemical Techniques; Excipients; Humans; Lactic Acid; Naphthoquinones; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Wound Healing | 2011 |
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Glucose; Glycolysis; Humans; Lactic Acid; Naphthoquinones; Neoplasms; Pyruvate Kinase | 2011 |
Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Survival; Disease-Free Survival; Enzyme Inhibitors; Female; Glucose; Humans; Immunohistochemistry; Lactic Acid; Mice, SCID; Naphthoquinones; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Pyruvate Kinase; Tissue Array Analysis; Xenograft Model Antitumor Assays | 2017 |
Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Topics: Animals; CD8-Positive T-Lymphocytes; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Humans; Hyaluronic Acid; Lactic Acid; Liver Neoplasms; Mice; Tumor Microenvironment | 2023 |